- ICH GCP
- US Clinical Trials Registry
- Clinical Trial NCT01075165
Efficacy of Spray Silicone in Alteration of Burn Scar
February 2, 2015 updated by: United States Army Institute of Surgical Research
The Efficacy of Spray Silicone in the Alteration of Physical Burn Scar Characteristics: A Double Blinded Randomized Controlled Trial
In a burn population, conduct a prospective, double-blinded, randomized, controlled clinical trial to determine the ability of spray silicone to alter the physical characteristics of burn scar compared to a placebo.
Study Overview
Status
Withdrawn
Conditions
Intervention / Treatment
Detailed Description
At study enrollment, the patient's scar will be evaluated using the vascularity category of the Vancouver Scar Scale.
The vascularity rating is a four item likert scale that rates the scar as normal (0), pink (1), red (2), or purple (3).
Scar height will be measured using a diagnostic ultrasound unit with a 20MHz transducer.27
Digital photographs will be taken with a color spectrum scale placed next to the scar.
Laser Doppler imaging (LDI) will be used to assess scar perfusion at the regions of interest to determine whether treatment with silicone spay results in measureable changes in scar perfusion as well as to establish the time course over which these changes may be expected to occur.
A spray template will then be created for the patient using thermoplastic material.
It will consist of three (3) circles with an area of .785
inches, spaced one inch apart, which will section off the test areas.
One of the areas will be treated with the spray silicone, one area will be sprayed with spray saline (to serve as a placebo), the remaining area will not be treated and therefore will serve as the control.
The order in which each area is treated will be determined using a randomized block, computerized allocation developed by the study statistician.
The spray silicone and spray saline will be applied via containers that conceal the contents and the patients will not be allowed to observe the application of the silicone or saline.
Although the patient will be blinded to the test areas that have substances applied to them, there will be no blinding in regard to the control area that receives no treatment.
The substances will be applied by trained investigators each weekday for a 12-week period to ensure the method of application is consistent.
Both substances will be applied at a distance of 1.5 inches from the surface of the skin for a one second period.
Patients will be instructed not to wash the treated area for 24 hours and not to apply pressure garments over the area.
The treated areas will be re-evaluated and photographed every two weeks for a 12 week period.
The clinician conducting the initial scar evaluation and re-evaluations will be blinded to the scar treatment.
Each patient will also complete a scar assessment scale.28
The patient's participation in the study will be concluded 12 weeks after the initial treatment and he/she will be given the option of continued use of the spray silicone, resumption/commencement of pressure garment use or the provision of another appropriate scar management program.
Because burn scar can take several months to years to reach the scar maturation phase, the patient will still be a candidate for an alternate scar management program if at the conclusion of this study they see no benefit from the use of spray silicone.
If at any time during the 12-week period the clinician determines that the scar is worsening, then the patient will be removed from the study and offered another scar management program.
Study Type
Interventional
Phase
- Not Applicable
Contacts and Locations
This section provides the contact details for those conducting the study, and information on where this study is being conducted.
Study Locations
-
-
Texas
-
Fort Sam Houston, Texas, United States, 78234
- USAISR
-
Fort Sam Houston, Texas, United States, 78234
- US Army Institute of Surgical Research
-
-
Participation Criteria
Researchers look for people who fit a certain description, called eligibility criteria. Some examples of these criteria are a person's general health condition or prior treatments.
Eligibility Criteria
Ages Eligible for Study
18 years to 60 years (Adult)
Accepts Healthy Volunteers
No
Genders Eligible for Study
All
Description
Inclusion Criteria:
- Military or civilian
- Between 18-60 years of age
- Subjects have experienced a deep partial thickness burn injury with a minimal size 2x6 inches in dimension
- Burn wounds must have healed by secondary intention
- Available for initial scar evaluation and bi-weekly assessments (30 minutes) and application of silicone and saline every weekday (5 minutes)
Exclusion Criteria:
- <18 or >60 years
- Available burn scar size is less then 2x6 inches
- Burn wounds healed by sheet grafting
- Unavailable for initial scar evaluation and bi-weekly assessments (30 minutes) and application of silicone and saline every weekday (5 minutes)
- Pre-existing medical conditions that have the potential to impair healing (i.e. Diabetes, Peripheral Arterial Disease, etc).
- Pregnant women will be excluded from the study because of the potential for pregnancy hormones to exacerbate the burn scar
Study Plan
This section provides details of the study plan, including how the study is designed and what the study is measuring.
How is the study designed?
Design Details
- Primary Purpose: Treatment
- Allocation: Randomized
- Interventional Model: Single Group Assignment
- Masking: Triple
Arms and Interventions
Participant Group / Arm |
Intervention / Treatment |
---|---|
Experimental: Silicone Spray
Apply spray silicone
|
application of silicone spray to predefined area qd 12 weeks
|
Placebo Comparator: Saline Spray
Apply Saline Spray
|
application of saline spray to predefined area qd 12 weeks
|
What is the study measuring?
Primary Outcome Measures
Outcome Measure |
Time Frame |
---|---|
Vascularity rating, scar height, and color of burn scar (spray silicone vs placebo vs untreated)
Time Frame: every 2 weeks for a 12 week period
|
every 2 weeks for a 12 week period
|
Collaborators and Investigators
This is where you will find people and organizations involved with this study.
Study record dates
These dates track the progress of study record and summary results submissions to ClinicalTrials.gov. Study records and reported results are reviewed by the National Library of Medicine (NLM) to make sure they meet specific quality control standards before being posted on the public website.
Study Major Dates
Study Start
March 1, 2011
Primary Completion (Actual)
December 1, 2014
Study Completion (Actual)
December 1, 2014
Study Registration Dates
First Submitted
February 23, 2010
First Submitted That Met QC Criteria
February 23, 2010
First Posted (Estimate)
February 24, 2010
Study Record Updates
Last Update Posted (Estimate)
February 4, 2015
Last Update Submitted That Met QC Criteria
February 2, 2015
Last Verified
February 1, 2015
More Information
Terms related to this study
Keywords
Additional Relevant MeSH Terms
Other Study ID Numbers
- H-09-041
This information was retrieved directly from the website clinicaltrials.gov without any changes. If you have any requests to change, remove or update your study details, please contact register@clinicaltrials.gov. As soon as a change is implemented on clinicaltrials.gov, this will be updated automatically on our website as well.
Clinical Trials on Burn Scar
-
Medstar Health Research InstituteActive, not recruitingBurn Scar | ScarUnited States
-
Bispebjerg HospitalUnknownBurn Scar PatientsDenmark
-
Medstar Health Research InstituteActive, not recruitingBurn Scar | Scar | Skin Graft ScarUnited States
-
University of PittsburghUnited States Department of DefenseTerminatedBurn Scar | Restrictive Scar Contracture | Restrictive Hypertrophic Scar | Burn Scar ContracturesUnited States
-
Centre hospitalier de l'Université de Montréal...Recruiting
-
University Hospital, LinkoepingCompletedBurn Scar | Burns | Burn Second DegreeSweden
-
Centre Hospitalier Régional Metz-ThionvilleNot yet recruiting
-
Kaiyang Lv, MD-PhDZimmer Medical Devices (Shanghai) Co., Ltd.RecruitingBurn Scar | Cryotherapy Effect | Scar; Previous Cesarean SectionChina
-
Centre hospitalier de l'Université de Montréal...Recruiting
-
Hangang Sacred Heart HospitalCompleted
Clinical Trials on silicone spray
-
Kaohsiung Veterans General Hospital.Unknown
-
Seton Healthcare FamilyCompleted
-
Mid Atlantic RetinaCompletedDiabetic Retinopathy | Retinal Detachment | Vitrectomy | Proliferative VitreoretinopathyUnited States
-
Centre hospitalier de l'Université de Montréal...Recruiting
-
Nova Scotia Health AuthorityRecruiting
-
Thammasat University HospitalActive, not recruiting
-
Centre Hospitalier Universitaire de Saint EtienneCompleted
-
Aristocrat Plastic Surgery and MedAestheticsSientra, Inc.; Erbe-medCompletedBreast AugmentationUnited States
-
International Medical Devices, Inc.CompletedRetrospective Analysis of the Safety and Effectiveness of Using the Silicone Block in Penile SurgeryPenile ImplantUnited States
-
Nova Scotia Cancer CentreWithdrawnSkin Cancer | Skin Neoplasm Malignant